Triple Bridge Acceleration Program “TBAP” aims to support the commercialization of academic research in the medical and life science fields.
In TBAP, research institutions, strategic companies, and financial investors collaborate to commercialize academic research.
Support
Preparing for Commercialization
Project Review
Connection to Strategic Companies
Academia
(Universities, research institutions, etc.）
- Improve competitiveness as a research institution.
- Enhance resources required for commercialization.
Businesses
(Pharmaceutical companies, medical device manufacturers, etc.)
- Improve access to seed opportunities.
- Mitigate early stage risk.
Investors
(VC, CVC, etc.)
- Gain greater access to investment opportunities.
- Enhance due diligence.
Collaboration
Team
Membership
Corporate
Shionogi & Co., Ltd.
Acceleration Programs served by TBAP
Japan Advanced Institute of Science and Technology
Kanazawa University
17 partner institutions in the Hokuriku region
19 partner institutions in the Hokkaido region
University of Tsukuba
Support / Affiliates
Management Company
TBAP is managed by AIFAM Asset Management in Japan, a wholly owned by AIFAM Group LLC (NY) .
Learn more about AIFAM